EPAS1 and chondrosarcoma: Chondrosarcoma patients carrying an amplified EPAS1 gene also tended to exhibit reduced disease-free survival compared to those without EPAS1 amplification (P = 0.0559; Fig. 1h and Supplementary Fig. 1f).